Neogen | NEOG - Operating Profit


Neogen reported $-3.3M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Agilent USD 399M 46M Mar/2026
Avanos Medical USD 8.9M 15.87M Mar/2026
Bio-Rad Laboratories USD 53.9M 10M Dec/2025
Cerus USD -1.45M 488K Dec/2024
Danaher USD 1.34B 158M Mar/2026
Idexx Laboratories USD 362.59M 46.98M Mar/2026
Illumina USD 239M 17M Mar/2026
Integra LifeSciences USD 11.47M 54.54M Mar/2026
Neogen USD -3.3M 2.08M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Quidel USD -31.8M 5.5M Mar/2026
Rockwell Medical USD 515K 1.84M Jun/2024
STAAR Surgical USD 17.4M 28.34M Mar/2026
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Utah Medical Products USD 2.44M 1.32M Dec/2025
Zoetis USD 865M 30M Mar/2026